instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, i... | METHOTREXATE, PREDNISONE, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 34743422 | 20,220,537 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, i... | METHOTREXATE, PREDNISONE, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 34743422 | 20,220,537 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type 1 diabetes mellitus'. | Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, i... | PREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34743422 | 17,973,829 | 2021-11-06 |
What is the weight of the patient? | Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, i... | 43.1 kg. | Weight | CC BY-NC | 34743422 | 20,220,537 | 2021-11-06 |
What was the administration route of drug 'TOCILIZUMAB'? | Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, i... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34743422 | 17,973,829 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amaurosis'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,483,394 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,483,394 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal haemorrhage'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ocular retrobulbar haemorrhage'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Orbital compartment syndrome'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Puncture site haemorrhage'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal artery occlusion'. | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | AMIODARONE, CLARITHROMYCIN, EPINEPHRINE, HEPARIN SODIUM, MEROPENEM, NOREPINEPHRINE, OSELTAMIVIR | DrugsGivenReaction | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the dosage of drug 'HEPARIN SODIUM'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | UNK, HIGH DOSE | DrugDosageText | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Amaurosis'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Not recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Mucosal haemorrhage'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Ocular retrobulbar haemorrhage'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Orbital compartment syndrome'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Puncture site haemorrhage'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
What was the outcome of reaction 'Retinal artery occlusion'? | Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
The value of mechanical circulatory support (MCS) in cardiogenic shock, especially the combination of the ECMELLA approach (Impella combined with ECMO), remains controversial... | Not recovered | ReactionOutcome | CC BY | 34743690 | 20,842,894 | 2021-11-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | ASPIRIN, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | ASPIRIN, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'POEMS syndrome'. | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | ASPIRIN, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal infarct'. | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | ASPIRIN, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
What was the outcome of reaction 'Cerebral infarction'? | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
What was the outcome of reaction 'Disease progression'? | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
What was the outcome of reaction 'POEMS syndrome'? | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
What was the outcome of reaction 'Renal infarct'? | Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
A 41-year-old woman was diagnosed with POEMS syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial gro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34744103 | 20,119,391 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device related infection'. | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | PANITUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | PANITUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | PANITUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
What was the administration route of drug 'PANITUMUMAB'? | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | Other | DrugAdministrationRoute | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
What was the outcome of reaction 'Enterocolitis'? | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
What was the outcome of reaction 'Haematochezia'? | A Case of Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34744108 | 20,128,308 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | COGNITIVE AND PSYCHOTIC SYMPTOMS IN A PATIENT WITH INFRATENTORIAL ARACHNOID CYST: CASE REPORT.
We present a case of a patient with treatment resistant hallucinatory experiences with incidental finding of an arachnoid cyst localized in the posterior infratentorial cranial fossa dorsally to the cerebellum. Psychological ... | ARIPIPRAZOLE, FLUVOXAMINE, OLANZAPINE, RISPERIDONE, VORTIOXETINE | DrugsGivenReaction | CC BY-NC-ND | 34744282 | 20,135,341 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by multiple episodes of venous and arterial thromboses or recurrent fetal losses in the presence of antiphospholipid antibodies against β... | DEXAMETHASONE, HEPARIN SODIUM, METHYLPREDNISOLONE, REMDESIVIR | DrugsGivenReaction | CC BY-NC | 34744467 | 20,194,431 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by multiple episodes of venous and arterial thromboses or recurrent fetal losses in the presence of antiphospholipid antibodies against β... | DEXAMETHASONE, HEPARIN SODIUM, METHYLPREDNISOLONE, REMDESIVIR | DrugsGivenReaction | CC BY-NC | 34744467 | 20,194,431 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retroperitoneal haemorrhage'. | A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by multiple episodes of venous and arterial thromboses or recurrent fetal losses in the presence of antiphospholipid antibodies against β... | DEXAMETHASONE, HEPARIN SODIUM, METHYLPREDNISOLONE, REMDESIVIR | DrugsGivenReaction | CC BY-NC | 34744467 | 20,194,431 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by multiple episodes of venous and arterial thromboses or recurrent fetal losses in the presence of antiphospholipid antibodies against β... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34744467 | 20,194,431 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Case Report: Serial MR Vessel Wall Imaging Visualizes the Response of Intracranial Plaques and Assists in Decision-Making.
Intracranial atherosclerotic disease (ICAD) is a dynamic process that leads to ischemic stroke. Symptomatic ICAD patients still suffer a high recurrent rate even under standard treatment. In this c... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, EZETIMIBE | DrugsGivenReaction | CC BY | 34744611 | 20,481,042 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Case Report: Serial MR Vessel Wall Imaging Visualizes the Response of Intracranial Plaques and Assists in Decision-Making.
Intracranial atherosclerotic disease (ICAD) is a dynamic process that leads to ischemic stroke. Symptomatic ICAD patients still suffer a high recurrent rate even under standard treatment. In this c... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, EZETIMIBE | DrugsGivenReaction | CC BY | 34744611 | 20,481,042 | 2021 |
What was the administration route of drug 'EZETIMIBE'? | Case Report: Serial MR Vessel Wall Imaging Visualizes the Response of Intracranial Plaques and Assists in Decision-Making.
Intracranial atherosclerotic disease (ICAD) is a dynamic process that leads to ischemic stroke. Symptomatic ICAD patients still suffer a high recurrent rate even under standard treatment. In this c... | Oral | DrugAdministrationRoute | CC BY | 34744611 | 20,481,042 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | LORAZEPAM | DrugsGivenReaction | CC BY | 34744838 | 20,918,691 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,940,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cognitive disorder'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,940,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed mood'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,940,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disinhibition'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | LORAZEPAM | DrugsGivenReaction | CC BY | 34744838 | 20,918,691 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,910,169 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extrapyramidal disorder'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,910,169 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,940,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | ARIPIPRAZOLE, LORAZEPAM, MIGLUSTAT | DrugsGivenReaction | CC BY | 34744838 | 20,910,169 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prescribed overdose'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | LORAZEPAM | DrugsGivenReaction | CC BY | 34744838 | 20,460,782 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | LORAZEPAM | DrugsGivenReaction | CC BY | 34744838 | 20,918,691 | 2021 |
What was the administration route of drug 'LORAZEPAM'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Oral | DrugAdministrationRoute | CC BY | 34744838 | 20,910,169 | 2021 |
What was the outcome of reaction 'Asthenia'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,940,275 | 2021 |
What was the outcome of reaction 'Catatonia'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,485,162 | 2021 |
What was the outcome of reaction 'Cognitive disorder'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,940,275 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,485,162 | 2021 |
What was the outcome of reaction 'Depressed mood'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,940,275 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,485,162 | 2021 |
What was the outcome of reaction 'Extrapyramidal disorder'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovered | ReactionOutcome | CC BY | 34744838 | 20,485,162 | 2021 |
What was the outcome of reaction 'Headache'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,940,275 | 2021 |
What was the outcome of reaction 'Paradoxical drug reaction'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,485,162 | 2021 |
What was the outcome of reaction 'Prescribed overdose'? | Case Report: "Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy".
We describe a case of an adolescent male with Niemann-Pick Type C (NP-C), a neurodegenerative lysosomal lipid storage disorder, who presented with recurrent catatonia which required repeated treatment with electroc... | Recovering | ReactionOutcome | CC BY | 34744838 | 20,460,782 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series.
Introduction: Limited data are available on the course of Coronavirus disease 2019 (COVID-19) in people with Multiple Sclerosis (MS). More real-world data are needed to help the MS community to manage MS treatment properly. In... | OCRELIZUMAB | DrugsGivenReaction | CC BY | 34744958 | 20,029,458 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series.
Introduction: Limited data are available on the course of Coronavirus disease 2019 (COVID-19) in people with Multiple Sclerosis (MS). More real-world data are needed to help the MS community to manage MS treatment properly. In... | CEFTRIAXONE, DARUNAVIR, HYDROXYCHLOROQUINE, RITONAVIR | DrugsGivenReaction | CC BY | 34744958 | 20,581,614 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anti-neuronal antibody'. | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
The development of autoimmune antibody panels has improved the diagnosis of paraneoplastic neurological disorders (PNDs) of the brain and spinal cord. Here, we present a case of a woman with a history of breast cancer who presented with a subacute... | DOCETAXEL, HUMAN IMMUNOGLOBULIN G, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34744969 | 20,447,575 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
The development of autoimmune antibody panels has improved the diagnosis of paraneoplastic neurological disorders (PNDs) of the brain and spinal cord. Here, we present a case of a woman with a history of breast cancer who presented with a subacute... | DOCETAXEL, HUMAN IMMUNOGLOBULIN G, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34744969 | 20,447,575 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraneoplastic myelopathy'. | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
The development of autoimmune antibody panels has improved the diagnosis of paraneoplastic neurological disorders (PNDs) of the brain and spinal cord. Here, we present a case of a woman with a history of breast cancer who presented with a subacute... | DOCETAXEL, HUMAN IMMUNOGLOBULIN G, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34744969 | 20,447,575 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Secondary cerebellar degeneration'. | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
The development of autoimmune antibody panels has improved the diagnosis of paraneoplastic neurological disorders (PNDs) of the brain and spinal cord. Here, we present a case of a woman with a history of breast cancer who presented with a subacute... | DOCETAXEL, HUMAN IMMUNOGLOBULIN G, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34744969 | 20,447,575 | 2021 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
The development of autoimmune antibody panels has improved the diagnosis of paraneoplastic neurological disorders (PNDs) of the brain and spinal cord. Here, we present a case of a woman with a history of breast cancer who presented with a subacute... | UNK, QMO | DrugDosageText | CC BY | 34744969 | 20,447,575 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | CETIRIZINE HYDROCHLORIDE, NATALIZUMAB | DrugsGivenReaction | CC BY | 34744991 | 20,429,206 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | CETIRIZINE HYDROCHLORIDE, NATALIZUMAB | DrugsGivenReaction | CC BY | 34744991 | 20,429,206 | 2021 |
What was the administration route of drug 'NATALIZUMAB'? | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34744991 | 20,429,206 | 2021 |
What was the dosage of drug 'CETIRIZINE HYDROCHLORIDE'? | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | 10 mg (milligrams). | DrugDosage | CC BY | 34744991 | 20,429,206 | 2021 |
What was the dosage of drug 'NATALIZUMAB'? | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | 300 mg (milligrams). | DrugDosage | CC BY | 34744991 | 20,429,206 | 2021 |
What was the outcome of reaction 'Abortion spontaneous'? | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | Recovered | ReactionOutcome | CC BY | 34744991 | 20,429,206 | 2021 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.
Objective: We aimed to determine the effectiveness of natalizumab (NTZ) by assessing overall No Evidence of Disease Activity 3 (NEDA-3) in a local Norwegian cohort. Background: NTZ is an immunomodulati... | Recovered | ReactionOutcome | CC BY | 34744991 | 20,429,206 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain oedema'. | Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.
Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four MS Centres in Central Italy, using d... | CLADRIBINE, TOZINAMERAN | DrugsGivenReaction | CC BY | 34744992 | 20,091,440 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple sclerosis relapse'. | Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.
Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four MS Centres in Central Italy, using d... | DIMETHYL FUMARATE, TOZINAMERAN | DrugsGivenReaction | CC BY | 34744992 | 20,210,222 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple sclerosis'. | Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.
Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four MS Centres in Central Italy, using d... | CLADRIBINE, TOZINAMERAN | DrugsGivenReaction | CC BY | 34744992 | 20,091,440 | 2021 |
What was the outcome of reaction 'Multiple sclerosis relapse'? | Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.
Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four MS Centres in Central Italy, using d... | Not recovered | ReactionOutcome | CC BY | 34744992 | 20,210,222 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Administration site extravasation'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,060,001 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion site extravasation'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion site haematoma'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion site vesicles'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral swelling'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product administered at inappropriate site'. | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the administration route of drug 'POTASSIUM CHLORIDE'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | 20 MILLILITRE | DrugDosageText | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the outcome of reaction 'Administration site extravasation'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,060,001 | 2021 |
What was the outcome of reaction 'Infusion site extravasation'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the outcome of reaction 'Infusion site haematoma'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the outcome of reaction 'Infusion site vesicles'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the outcome of reaction 'Peripheral swelling'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
What was the outcome of reaction 'Product administered at inappropriate site'? | Extravasation of Concentrated Potassium Chloride: A Case Report.
The extravasation of potassium chloride will cause serious harm, especially if it is not diagnosed or treated promptly. Objective:to report the clinical course of a patient who was suffering a potassium extravasation and to discuss steps that can be done ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34745392 | 20,057,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions.
Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID-19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID-19 and mucormycosis.
pmc1 ... | ACETYLCYSTEINE, AMLODIPINE BESYLATE, AMPHOTERICIN B, COLCHICINE, DEXAMETHASONE, INSULIN GLARGINE, IVERMECTIN, OXYGEN, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 34745621 | 20,205,658 | 2021-10 |
What was the administration route of drug 'REMDESIVIR'? | Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions.
Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID-19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID-19 and mucormycosis.
pmc1 ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34745621 | 20,205,658 | 2021-10 |
What was the dosage of drug 'ACETYLCYSTEINE'? | Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions.
Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID-19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID-19 and mucormycosis.
pmc1 ... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34745621 | 20,205,658 | 2021-10 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.